Correction to: Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures

Cancer Immunol Immunother. 2022 Apr;71(4):999. doi: 10.1007/s00262-021-03086-0.

Yvonne H F Teng^{1

2

3}, Hong Sheng Quah^{1

3}, Lisda Suteja^{1

2}, João M L Dias⁴, Annalisa Mupo⁵, Rachael J M Bashford-Rogers⁶, George S Vassiliou⁷, Melvin L K Chua^{3

8}, Daniel S W Tan^{1

2

3}, Darren W T Lim^{2

3

9}, N Gopalakrishna Iyer^{10

11

12}

¹ Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.
² Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
³ Duke-NUS Medical School, Singapore, Singapore.
⁴ Hutchison/MRC Research Centre, MRC Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK.
⁵ Babraham Research Institute, Cambridge, CB22 3AT, UK.
⁶ Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Dr, Headington, Oxford, OX3 7BN, UK.
⁷ Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge Biomedical Campus, Puddicombe Way, Cambridge, CB2 0AW, UK.
⁸ Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
⁹ Institute of Molecular and Cell Biology, A-STAR, Singapore, Singapore.
¹⁰ Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore. gopaliyer@singhealth.com.sg.
¹¹ Duke-NUS Medical School, Singapore, Singapore. gopaliyer@singhealth.com.sg.
¹² Department of Head and Neck Surgery, National Cancer Centre Singapore, Singapore, Singapore. gopaliyer@singhealth.com.sg.

No abstract available

Publication types